Approval to Covaxin for children aged between 2-18 years...

New Delhi [India], October 12 (ANI): After the evaluation of data Covaxin is yet to get approval by the Drugs...

Sputnik Light Covid vaccine gets permission for Phase 3...

New Delhi [India], September 15 (ANI): The Drug Controller General of India has given its approval to the...

DCGI approves Hetero's Tocilizumab for treatment of COVID-19...

Hyderabad (Telangana) [India], September 6 (ANI): Hetero announced on Monday that the Drug Controller General of...

Biological E gets drug regulator's approval to conduct phase...

New Delhi [India], September 2 (ANI): The Drug Controller General of India (DCGI) on Wednesday granted permission to...

Enzene Biosciences Ltd. obtains a Marketing Authorization for...

Pune (Maharashtra) [India], August 27 (ANI/PRNewswire): Enzene Biosciences Ltd. "Enzene" announces a successful...

Enzene Biosciences Ltd. obtains Marketing Authorization for...

Pune (Maharashtra) [India], August 20 (ANI/PRNewswire): Enzene Biosciences Ltd. "Enzene" announces a successful...

Pfizer, Johnson and Johnson yet to apply for license of...

New Delhi [India], July 15 (ANI): The Drug Controller General of India (DCGI) has urged Pfizer, Johnson and...

Zydus Cadila seeks nod for its COVID-19 vaccine ZyCoV-D, aims...

New Delhi [India], July 1 (ANI): The pharmaceutical firm Zydus Cadila on Thursday informed that it has applied for...

DCGI grants SII permission to manufacture Sputnik V for...

New Delhi [India], June 4 (ANI): The Drug Controller General of India (DCGI) on Friday granted the approval to the...

Children can't be vaccinated currently, trials on below 18...

New Delhi [India], June 4 (ANI): Centre through an affidavit on Friday informed the Delhi High Court that on May 12,...

SII seeks DCGI's permission for test license to manufacture...

New Delhi [India], June 3 (ANI): Indian vaccine manufacturing company Serum Institute of India (SII) has sought...

COVID-19: MSN Laboratories initiates Phase III clinical trial...

New Delhi [India], May 26 (ANI): MSN Laboratories Private Limited (MSN) is initiating phase III clinical trial of...